Concepedia

Virus-Tumor Interactome Screen Reveals ER Stress Response Can Reprogram Resistant Cancers for Oncolytic Virus-Triggered Caspase-2 Cell Death

Douglas J. Mahoney, Charles Lefebvre, Kristina J. Allan, J Brun, Cina A. Sanaei, Stephen Baird, Nelson Pearce, S. A.‐M. Grönberg, Brian C. Wilson, Mikael Prakesh,

Cancer Cell · 2011 · 100 citations · 23 references

DOIFull text

Open access

Concepts

References

23

Functional Role of Type I and Type II Interferons in Antiviral Defense

Ulrike Müller, Ulrich Steinhoff, Luiz F. L. Reis et al. · Science · 1994 · 2.5K citations · Full text

, , +15

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents

David F. Stojdl, Brian D. Lichty, Benjamin R. tenOever et al. · Cancer Cell · 2003 · 848 citations · Full text

, , +14

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

David F. Stojdl, Brian D. Lichty, Shane Knowles et al. · Nature Medicine · 2000 · 816 citations

, , +16

The PIDDosome, a Protein Complex Implicated in Activation of Caspase-2 in Response to Genotoxic Stress

Antoine Tinel, Jürg Tschopp · Science · 2004 · 666 citations

, , +16

Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors.

Thomas C. Hamilton, Robert C. Young, Wilma M. McKoy et al. · PubMed · 1983 · 543 citations

, , +15